Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 3,060.00
-40.00 (-1.29%)
Sep 1, 2026, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 142.75 billion as of September 1, 2026. Its market cap has decreased by -47.99% in one year.
Market Cap
142.75B
Enterprise Value
61.69B
Revenue
2.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,060.00
ChartMarket Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 142.75B, a decrease of -40.18%. That is a compound annual growth rate of -2.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 142.75B | -50.16% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoImmuneTech | 248.16B |
| Bioneer | 214.48B |
| GC Cell | 202.72B |
| HLB Therapeutics | 196.24B |
| Anterogen.Co.,Ltd. | 148.59B |
| GC Genome | 141.20B |
| Genexine | 124.39B |
| MedPacto | 93.91B |